A5044436835- Blood Pressure and Hypertension Studies
- COVID-19 Clinical Research Studies
- Medical and Biological Ozone Research
- Cardiac Health and Mental Health
- Drug-Induced Adverse Reactions
- Healthcare Systems and Public Health
- Lipoproteins and Cardiovascular Health
- Pulmonary Hypertension Research and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- SARS-CoV-2 and COVID-19 Research
- Diet and metabolism studies
- Adipokines, Inflammation, and Metabolic Diseases
- Drug-Induced Hepatotoxicity and Protection
- Cardiovascular Disease and Adiposity
- Obesity, Physical Activity, Diet
- Physical Activity and Health
- Hormonal Regulation and Hypertension
- Pharmacology and Obesity Treatment
- Systemic Sclerosis and Related Diseases
- Cardiovascular Health and Risk Factors
Volgograd State Medical University
2020
Aim. To assess awareness of blood pressure (BP) level, adherence to therapy and achievement target BP in residents Russian regions as part the 2023 hypertension (HTN) screening campaign. Material methods. During May 2023, 4613 participants from 23 cities Russia took screening. Participation was voluntary without restrictions on sex. All patients aged over 18 years. screening, pulse were measured three times using automatic or mechanical monitors, a questionnaire about behavioral risk...
Цель. Целью исследования явилась оценка эффективности и приверженности гиполипидемической терапии, частоты развития сердечно<со< судистых осложнений в течение 3<летнего периода наблюдения рамках регистра РЕНЕССАНС (Регистр пациентов с СГХС очень высокого сЕрдечно<Сосудистого риска недоСтАточной эффективНоСтью проводимой терапии). Материал методы. является открытым национальным наблюдательным исследованием включает больных семейной ги< перхолестеринемией (СГХС), а также...
Aim. To evaluate the prevalence of covert visceral adiposity (CVA) in males with type 2 diabetes (DM2) and to assess its relation subclinical atherosclerosis food-related behavior. Material methods. study, 72 middle age included (54,1±0,7 y.o.). Mean duration DM25,1±1,1 years. In 28 patients DM2 had been diagnosed first time study. Those body mass index (BMI) >30 kg/m waist circumference >102 cm were excluded. All underwent standard clinical investigations additionally, leptin levels...